US Patent 10953032 Cyclic dinucleotides as anticancer agents
Patent 10953032 was granted and assigned to Bristol-Myers Squibb on March, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 30, 2018
0
Date of Patent
March 23, 2021
0
Patent Applicant
Patent Application Number
16642424
0
Patent Citations Received
Patent Inventor Names
Brian E. Fink
0
Dharmpal S. Dodd
0
Yong Zhang
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10953032 Cyclic dinucleotides as anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
